In Vitro Analysis of VEGF and HGF Production by Fibroblast in Cultured Dermal Substitute Combined with EGF-Incorporating Top Dressing

Emi Iijima, Daichi Daichi Toyoda, Akiko Yamamoto, Misato Kuroyanagi, Yoshimitsu Yoshimitsu Kuroyanagi

R&D Center for Artificial Skin, School of Allied Health Sciences, Kitasato University, Kanagawa, Japan.

DOI: 10.4236/ojrm.2014.31002                

Abstract

This study aimed to investigate the potential of cultured dermal substitute (CDS) to release angiogenic growth factors when laminated with a membrane containing epidermal growth factor (EGF) as a top dressing. Membranes were prepared by air-drying a solution of hyaluronic acid (HA) and collagen (Col) with or without EGF. Membranes were designed to contain EGF at concentrations of 0, 0.1, 0.2 or 0.5 μg/cm². CDS was prepared by incorporating fibroblasts into a collagen gel combined with a cross-linked HA spongy matrix, followed by culturing for 5 days. CDS was designed to contain fibroblasts at a density of 2 × 105 (Group I) or 4 × 105 cells/cm2> (Group II). CDS was elevated at the interface between air and culture medium, on the top of which each membrane was placed. This culture system was employed as a wound surface model. Metabolic activity of the fibroblasts in the CDS cultured for 7 days on a wound surface model was measured by MTT assay. The amounts of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) after 7 days of cultivation were measured by using ELISA. Membranes containing EGF ranging from 0.1 to 0.5 μg/cm2> facilitated production of both VEGF and HGF, as compared with control membranes without EGF. However, a membrane containing EGF at a concentration of 0.5 μg/cm2> failed to facilitate fibroblast cytokine production in Group I. These results demonstrated that the EGF-incorporating membrane was able to stimulate fibroblasts in the CDS to synthesize an increased amount of VEGF and HGF in a dose-dependent manner.

Keywords

Cultured Dermal Substitute; Fibroblast; Collagen; Hyaluronic Acid; Epidermal Growth Factor

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Kondo, S., Niiyama, H., Yu, A. and Kuroyanagi, Y. (2012) Evaluation of a Wound Dressing Composed of Hyaluronic Acid and Collagen Sponge Containing Epidermal Growth Factor in Diabetic Mice. Journal of Biomaterials Science, 23, 1729-1740. http://dx.doi.org/10.1163/092050611X555687
[2]	Yu, A., Niiyama, H., Kondo, S., Yamamoto, A., Suzuki, R. and Kuroyanagi, Y. (2013) Wound Dressing Composed of Hyaluronic Acid and Collagen Containing EGF or bFGF: Comparative Culture Study. Journal of Biomaterials Science, 24, 1015-1026. http://dx.doi.org/10.1080/09205063.2012.731375
[3]	Kuroyanagi, Y., Kubo K., Matsui, H., Kim, H.-J., Numari, S., Mabuchi, Y. and Kagawa, S. (2004) Establishment of Banking System for Allogeneic Cultured Dermal Substitute. Artificial Organs, 28, 13-21. http://dx.doi.org/10.1111/j.1525-1594.2004.07318.x
[4]	Kubo, K. and Kuroyanagi, Y. (2005) A Study of Cytokines Released from Fibroblasts in Cultured Dermal Substitute. Artificial Organs, 29, 845-849. http://dx.doi.org/10.1111/j.1525-1594.2005.00138.x
[5]	Kobayashi, S., Kubo, K., Matsui, H., Torikai, K. and Kuroyanagi, Y. (2006) Skin Regeneration for Giant Pigmented Nevus Using Autologous Cultured Dermal Substitutes and Epidermis Separated from Nevus Skin. Annals of Plastic Surgery, 56, 176-181. http://dx.doi.org/10.1097/01.sap.0000197199.40281.76
[6]	Fujimori, Y., Ueda, K., Fumimoto, H., Kubo, K. and Kuroyanagi, Y. (2006) Skin Regeneration for Children with Burn Scar Contracture Using Autologous Cultured Dermal Substitutes and Superthin Auto-Skin Grafts: Preliminary Clinical Study. Annals of Plastic Surgery, 57, 408-414. http://dx.doi.org/10.1097/01.sap.0000237057.49772.4f
[7]	Kashiwa, N., Ito, O., Ueda, T., Kubo, K., Matsui, H. and Kuroyanagi, Y. (2004) Treatment of Full-Thickness Skin Defect with Concomitant Grafting of 6-Fold Extended Mesh Auto-Skin and Allogeneic Cultured Dermal Substitute. Artificial Organs, 28, 444-450. http://dx.doi.org/10.1111/j.1525-1594.2004.00009.x
[8]	Ohtani, T., Okamoto, K., Kaminaka, C., Kishi, T., Sakurane, M., Yamamoto, Y., Ueda, K., Kubo, K., Kuroyanagi, Y. and Furukawa, F. (2004) Digital Gangrene Associated with Idiopathic Hypereosinophilia: Treatment with Allogeneic Cultured Dermal Substitute (CDS). European Journal of Dermatology, 14, 168-171.
[9]	Moroi, Y., Fujita, S., Fukagawa, S., Mashino, T., Goto, T., Masuda, T., Urabe, K., Kubo, K., Matsui, H., Kagawa, S., Kuroyanagi, Y. and Furue, M. (2004) Clinical Evaluation of Allogeneic Cultured Dermal Substitutes for Intractable skin Ulcers after Tumor Resection. European Journal of Dermatology, 14, 172-176.
[10]	Yamada, N., Uchinuma, E. and Kuroyanagi, Y. (2012) Clinical Trial of Allogeneic Cultured Dermal Substitutes for Intractable Skin Ulcers. Journal of Artificial Organs, 15, 193-199. http://dx.doi.org/10.1007/s10047-011-0618-0
[11]	Sawa, M. and Kuroyanagi, Y. (2013) Potential of a Cryopreserved Cultured Dermal Substitute Composed of Hyaluronic Acid and Collagen to Release Angiogenic Cytokine. Journal of Biomaterials Science, 24, 224-238.
[12]	Chen, W.Y.J. and Abatangelo, G. (1999) Functions of Hyaluronan in Wound Repair. Wound Repair and Regeneration, 7, 79-89. http://dx.doi.org/10.1046/j.1524-475X.1999.00079.x
[13]	Pardue, E.L., Ibrahim, S. and Ramamurthi, A. (2008) Role of Hyaluronan in Angiogenesis and Its Utility to Angiogenic Tissue Engineering. Organogenesis, 4, 203-214. http://dx.doi.org/10.4161/org.4.4.6926
[14]	Ellis, I., Grey, A.M., Schor, A.M. and Schor, S.L. (1992) Antagonistic Effects of TGF-Beta 1 and MSF on Fibroblast Migration and Hyaluronic Acid Synthesis. Possible Implications for Dermal Wound Healing. Journal of Cell Science, 102, 447-456.
[15]	Ellis, I. and Schor, S.L. (1997) Differential Response of Fetal and Adult Fibroblasts to Cytokines: Cell Migration and Hyaluronan Synthesis. Development, 124, 1593-1600.
[16]	West, D.C., Hampson, I.N., Arnold, F. and Kumar, S. (1985) Angiogenesis Induced by Degradation Products of Hyaluronic Acid. Science, 228, 1324-1326. http://dx.doi.org/10.1126/science.2408340
[17]	Sattar, A., Rooney, P., Kumar, S., Pye, D., West, D.C., Scott, I. and Ledger, P. (1994) Application of Angiogenic Oligosaccharides of Hyaluronan Increases Blood Vessel Numbers in Rat Skin. Journal of Investigative Dermatology, 103, 576-579. http://dx.doi.org/10.1111/1523-1747.ep12396880
[18]	Lees, V.C., Fan, T.P. and West, D.C. (1995) Angiogenesis in a Delayed Revascularization Model Is Accelerated by Angiogenic Oligosaccharides of Hyaluronan. Laboratory Investigation, 73, 259-266.
[19]	John, W.Y. and Abataneqelo, G. (1999) Functions of Hyaluronan in Wound Repair. Wound Repair and Regeneration, 7, 79-89. http://dx.doi.org/10.1046/j.1524-475X.1999.00079.x
[20]	Deed, R., Rooney, P., Kumar, P., Norton, J.D., Smith, L., Freemont A.J. and Kumar, S. (1997) Early-Response Gene Signalling Is Induced by Angiogenic Oligosaccharides of Hyaluronan in Endothelial Cells. Inhibition by Non-Angiogenic, High-Molecular-Weight Hyaluronan. International Journal of Cancer, 71, 251-256. http://dx.doi.org/10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J
[21]	Postlethwaite, A.E., Seyer, J.M. and Kang, A.H. (1978) Chemotactic Attraction of Human Fibroblasts to Type I, II, and III Collagens and Collagen-Derived Peptides. Proceedings of the National Academy of Sciences of USA, 75, 871-875. http://dx.doi.org/10.1073/pnas.75.2.871
[22]	Ohara, H., Ichikawa, S., Matsumoto, H., Akiyama, M., Fujimoto, N., Kobayashi, T. and Tajima, S. (2010) CollagenDerived Dipeptide, Proline-Hydroxyproline, Stimulates Cell Proliferation and Hyaluronic Acid Synthesis in Cultured Human Dermal Fibroblasts. The Journal of Dermatology, 37, 330-338. http://dx.doi.org/10.1111/j.1346-8138.2010.00827.x
[23]	Nurata, M., Okuda, K., Moose, M., Kubo, K., Kuroyanagi, Y., Wolff, L.F. and Yoshie, H. (2008) Roof Coverage with Cultured Gingival Dermal Substitute Composed of Gingival Fibroblasts and Matrix: A Case Series. The International Journal of Periodontics and Restorative Dentistry, 28, 461-467.
[24]	Moulin, V. (1995) Growth Factors in Skin Wound Healing. European Journal of Cell Biology, 68, 1-7.
[25]	Cooper, D.M., Yu, E.Z., Hennessey, P., Ko, F. and Robson, M.C. (1994) Determination of Endogenous Cytokines in Chronic Wounds. Annals of Surgery, 219, 688-691. http://dx.doi.org/10.1097/00000658-199406000-00012
[26]	Cohen, S. (1962) Isolation of a Mouse Submaxillary Gland Protein Accelerating Incisor Eruption and Eyelid Opening in the New-Born Animal. The Journal of Biological Chemistry, 237, 1555-1562.
[27]	Carpenter, G. and Cohen, S. (1976) Human Epidermal Growth Factor and the Proliferation of Human Fibroblasts. Journal of Cellular Physiology, 88, 227-237. http://dx.doi.org/10.1002/jcp.1040880212
[28]	Yu, A., Matsuda, Y., Takeda, A., Uchinuma, E. and Kuroyanagi, Y. (2012) Effect of EGF and bFGF on Fibroblast Proliferation and Angiogenic Cytokine Production from Cultured Dermal Substitutes. Journal of Biomaterials Science, 23, 1315-1324.